Why Pfizer Will Make More Money Than Originally Expected in 2021

We've all known for quite a while that Pfizer (NYSE:PFE) was likely to make billions of dollars from its COVID-19 vaccine. Granted, the big drugmaker has to share any revenue generated with its partner, BioNTech (NASDAQ:BNTX). But a lot of money is about to begin flowing into Pfizer's coffers thanks to Comirnaty, the brand name the company bestowed on COVID-19 vaccine BNT162b2.